Medicare Enrolled

Dr. Rodman Rogers, M.D.

Urology Physician · San Francisco, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2186 GEARY BLVD, San Francisco, CA 94115
4159220347
In practice since 2006 (19 years)
NPI: 1073617023 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rogers from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rogers? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rogers

Dr. Rodman Rogers is an urology physician in San Francisco, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rogers performed 1,896 Medicare services across 1,205 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rogers received a total of $10,115 from 48 pharmaceutical and/or device companies across 385 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rogers is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 42% volume in CA $10,115 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,896
Medicare services
Top 42% in CA for urology physician
1,205
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~100 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,064 $103 $292
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
201 $62 $176
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
104 $228 $635
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
99 $11 $28
Leuprolide acetate (for depot suspension), 7.5 mg 99 $136 $500
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
69 $132 $391
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
57 $135 $424
Simple change of bladder tube 43 $87 $243
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
35 $133 $365
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
33 $368 $970
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
32 $7 $33
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
21 $34 $86
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
13 $112 $287
3D radiographic procedure with computerized image postprocessing
A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data.
13 $34 $87
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
13 $27 $69
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,115
Total received (2018-2024)
Avg $1,445/year across 7 years
Top 20% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
385
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,099 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,358
2023
$1,500
2022
$1,756
2021
$1,766
2020
$995
2019
$1,592
2018
$1,147

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$517
Astellas Pharma US Inc
$221
Antares Pharma, Inc.
$92
Janssen Biotech, Inc.
$83
PFIZER INC.
$74
Blue Earth Diagnostics Limited
$68
Myriad Genetic Laboratories, Inc.
$67
ABBVIE INC.
$65
Becton, Dickinson and Company
$45
Olympus America Inc.
$41
IMMUNITYBIO, INC.
$35
UROGEN PHARMA, INC.
$32
C. R. Bard, Inc. & Subsidiaries
$18
Top 3 companies account for 61.1% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,842
Sumitomo Pharma America, Inc.
$1,236
Janssen Biotech, Inc.
$785
UROVANT SCIENCES INC
$780
AbbVie Inc.
$501
Boston Scientific Corporation
$484
Blue Earth Diagnostics Limited
$341
BOSTON SCIENTIFIC CORPORATION
$319
ABBVIE INC.
$306
PFIZER INC.
$298
Ferring Pharmaceuticals Inc.
$266
NeoTract Inc.
$241
Dendreon Pharmaceuticals LLC
$228
Dornier MedTech America, Inc
$205
AbbVie, Inc.
$195
PROCEPT BioRobotics Corporation
$170
Allergan Inc.
$147
Antares Pharma, Inc.
$135
TOLMAR Pharmaceuticals, Inc.
$120
Janssen Scientific Affairs, LLC
$118
Bayer HealthCare Pharmaceuticals Inc.
$96
Agiliti Surgical, Inc.
$92
Merck Sharp & Dohme Corporation
$85
KARL STORZ Endoscopy-America
$80
Myovant Sciences Inc.
$78
ROCHESTER MEDICAL CORPORATION
$78
Medtronic USA, Inc.
$77
Myriad Genetic Laboratories, Inc.
$67
Endo Pharmaceuticals Inc.
$64
Olympus America Inc.
$59
C. R. BARD, INC. & SUBSIDIARIES
$58
Allergan, Inc.
$58
UROGEN PHARMA, INC.
$58
GE HealthCare
$56
Becton, Dickinson and Company
$45
Rochester Medical Corporation
$44
Photocure Inc
$43
Coloplast Corp
$38
AngioDynamics, Inc.
$35
IMMUNITYBIO, INC.
$35
Bayer Healthcare Pharmaceuticals Inc.
$29
UroGen Pharma, Inc.
$24
180 Medical, Inc.
$18
C. R. Bard, Inc. & Subsidiaries
$18
SRS Medical Systems, Inc.
$17
Acerus Pharmaceuticals Corporation
$16
Sagent Pharmaceuticals
$15
AKRIMAX PHARMACEUTICALS, LLC
$15
Top 3 companies account for 38.2% of all-time payments
Associated products mentioned in payments ›
16 FR. FLEXIBLE VIDEO CYSTOSCOPE · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axumin · BOTOX · BOTOX - UROLOGY · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · CYSVIEW · Cysview · Dornier MedTech · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLEX-XC CMOS URETEROSCOPE 8.5 FR X 675MM · FLEXIVA · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENERAL - BPH · GENERAL - FEMALE SUI · GENERAL BPH · General - Kidney Stone Disease · Glydo · GreenLight XPS · INTERSTIM · JELMYTO · KEYTRUDA · LITHOCATCH · LITHOVUE · LITHOVUE EMPOWER · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · NanoKnife · Natesto · Nubeqa · ORGOVYX · PENILE & TESTICULAR RECONSTRUCTN · POSLUMA · PROLARIS · PROVENGE · REZUM · SELF-CATH · SPEEDICATH · Stendra · TOVIAZ · UroCuff · UroLift · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in San Francisco?
Compare urology physicians in the San Francisco area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
134
Per 100K population
16.0
County median income
$141,446
Nearest hospital
KAISER FOUNDATION HOSPITAL - SAN FRANCISCO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rogers is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 20% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rogers experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rogers performed 1,064 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rogers receive payments from pharmaceutical companies?
Yes. Dr. Rogers received a total of $10,115 from 48 companies across 385 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rogers's costs compare to other urology physicians in San Francisco?
Dr. Rogers's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rogers) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →